2Stupka E, deShazo R. Asthma in seniors: Part 1. Evidence for underdiagnosis,undertreatment, and increasing morbidity and mortality[J]. AmJ Med, 2009,122(1): 6-11.
3Scichilone N, Pedone C, Battaglia S, et al. Diagnosis and managementof asthma in the elderly[J].E ut J Intern Med, 2014, 25(4): 336-42.
4Haughneya J, Aubierb M, J0rgensen L, et al. Comparing asthma treatmentin elderly versus younger patients [J]. Respiratory Medicine, 2011,105(6): 838-45.
5Yoshida M, Nakano T, Fukuyama S, et al. Effects of tioixopium on lungfunction in severe asthmatics with or without emphysematous changes[J].Palm Hwrmacol Ther, 2013, 26(2): 159-66.
6Creticos P, Knobil K, Edwards LD, et al. Loss of response to treatmentwith leukotriene receptor antagonists but not inhaled corticosteroids inpatients over 50 years of age [J]. Ann Allergy Asthma Immunol, 2002,88(4): 401-9.
7Korenblat PE, Kemp JP, Scherger JE, et al. Effect of age on responseto zaflrlukast in patients with asthma in the Accolate Clinical Experienceand Pharmacoepidemiology Trial (ACCEPT)[J]. Ann Allergy AsthmaImmunol, 2000, 84(2): 217-25.
8Hanania NA. Targeting airway inflammation in asthma: current and futuretherapies[J]. Chest, 2008, 133(4); 989-98.
9Cox L, Cohn JR. Duration of allergen immunotherapy in respiratory allergy:when is enough, enough- [J]. Ann Allergy Asthma Immunol72007, 98(5): 416-26.
10Akinbami LJ, Moorman JE Bailey C, et al. Trends in asthma prevalence,health care use, and mortality in the United States, 2001-2010[J]. NCHS Data Bnef, 2012, (94):l-8.
